Evogene logo

Evogene Share Price Today

(NASDAQ: EVGN)

Evogene share price is $1.47 & ₹128.03 as on 5 Feb 2025, 2.30 'hrs' IST

$1.47

Market is closed - opens 8 PM, 05 Feb 2025

View live Evogene share price in Dollar and Rupees. Guide to invest in Evogene stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Evogene, along with analyst recommendations, forecasts, and comprehensive financials.

Evogene share price movements

  • Today's Low: $1.45
    Today's High: $1.55

    Day's Volatility :6.3%

  • 52 Weeks Low: $1.20
    52 Weeks High: $10.40

    52 Weeks Volatility :88.46%

Evogene (EVGN) Returns

PeriodEvogene LtdIndex (Russel 2000)
3 Months
-23.83%
0.0%
6 Months
-65.41%
0.0%
1 Year
-80.66%
0.0%
3 Years
-89.19%
-11.7%

Evogene (EVGN) Key Statistics

in dollars & INR

Previous Close
$1.47
Open
$1.49
Today's High
$1.5475
Today's Low
$1.45
Market Capitalization
$10.2M
Today's Volume
$22.3K
52 Week High
$10.4
52 Week Low
$1.2
Revenue TTM
$9.4M
EBITDA
$-19.7M
Earnings Per Share (EPS)
$-4.46
Profit Margin
-210.26%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-82.37%

How to invest in Evogene Stock (EVGN) from India?

It is very easy for Indian residents to invest directly in Evogene from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Evogene stock in both Indian Rupees (INR) and US Dollars (USD). Search for Evogene or EVGN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Evogene or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Evogene shares which would translate to 0.592 fractional shares of Evogene as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Evogene, in just a few clicks!

Returns in Evogene (EVGN) for Indian investors in Rupees

The Evogene stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Evogene investment value today

Current value as on today

₹24,207

Returns

₹75,793

(-75.79%)

Returns from Evogene Stock

₹80,658 (-80.66%)

Dollar Returns

₹4,865 (+4.86%)

Indian investors sentiment towards Evogene (EVGN)

-40%

Period: Jan 5, 2025 to Feb 4, 2025. Change in 30 Days versus previous period

Search interest for Evogene Stock from India on INDmoney has decreased by -40% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Evogene

    Analyst Recommendation on Evogene

    Buy

      87%Buy

      12%Hold

      0%Sell

    Based on 8 Wall street analysts offering stock ratings for Evogene(by analysts ranked 0 to 5 stars)

    Based on 8 analyst
    • Current
    • 1M Ago
    • 3M Ago
    Buy
    7
    7
    8
    Hold
    1
    1
    1
    Sell
    0
    0
    0

    Analyst Forecast on Evogene Stock (EVGN)

    What analysts predicted

    Upside of 452.72%

    Target:

    $8.13

    Current:

    $1.47

    Insights on Evogene Stock (Ticker Symbol: EVGN)

    • Price Movement

      In the last 6 months, EVGN stock has moved down by -69.6%
    • Increasing Revenue

      Revenue is up for the last 2 quarters, 914.0K → 1.79M (in $), with an average increase of 49.1% per quarter
    • Decreasing Net Profit

      Netprofit is down for the last 3 quarters, -3.86M → -7.63M (in $), with an average decrease of 40.5% per quarter
    • EVGN vs ALNY (1 yr)

      In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 58.6% return, outperforming this stock by 139.5%
    • EVGN vs VRTX (3 yr)

      In the last 3 years, Vertex Pharmaceuticals Incorporated has given 88.8% return, outperforming this stock by 177.7%
    • Price to Sales

      ForEVGN every $1 of sales, investors are willing to pay $0.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $16.6 for every $1 of sales.

    Evogene Technicals Summary

    Sell

    Neutral

    Buy

    Evogene is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

    Evogene (EVGN) Vs Peers

    Company Name1 Month6 Month1 Year3 Years5 Years
    Evogene Ltd logo
    -20.54%
    -65.41%
    -80.66%
    -89.19%
    -90.45%
    Biontech Se logo
    -0.32%
    51.19%
    24.81%
    -30.66%
    288.02%
    Regeneron Pharmaceuticals, Inc. logo
    -6.9%
    -37.55%
    -28.89%
    7.15%
    74.63%
    Vertex Pharmaceuticals Incorporated logo
    16.87%
    0.96%
    13.03%
    93.36%
    95.94%
    Alnylam Pharmaceuticals, Inc. logo
    17.76%
    5.53%
    59.46%
    84.7%
    118.8%
    Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
    Evogene Ltd logo
    0.3
    NA
    0.0
    -4.11
    -0.82
    -0.28
    NA
    2.38
    Biontech Se logo
    160.8
    NA
    0.04
    -3.32
    -0.02
    -0.01
    NA
    79.73
    Regeneron Pharmaceuticals, Inc. logo
    16.64
    16.64
    1.08
    44.92
    0.17
    0.07
    NA
    272.04
    Vertex Pharmaceuticals Incorporated logo
    32.84
    NA
    1.21
    0.49
    -0.03
    0.12
    NA
    60.65
    Alnylam Pharmaceuticals, Inc. logo
    NA
    NA
    -0.49
    -0.18
    -15.01
    -0.03
    NA
    0.25
    Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
    Evogene Ltd logo
    Buy
    $10.2M
    -90.45%
    0.3
    -210.26%
    Biontech Se logo
    Buy
    $29.7B
    288.02%
    160.8
    -15.36%
    Regeneron Pharmaceuticals, Inc. logo
    Buy
    $74.0B
    74.63%
    16.64
    33.61%
    Vertex Pharmaceuticals Incorporated logo
    Buy
    $118.9B
    95.94%
    32.84
    -4.51%
    Alnylam Pharmaceuticals, Inc. logo
    Buy
    $35.0B
    118.8%
    NA
    -15.86%

    About Evogene

    Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health, agriculture, and other industrial applications through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, gastrointestinal inflammatory related disorders, and antimicrobial resistance organisms. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.
    Organization
    Evogene
    Employees
    142
    CEO
    Mr. Ofer Haviv CPA
    Industry
    Health Technology

    Management People of Evogene

    NameTitle
    Mr. Ofer Haviv CPA
    CEO & President
    Dr. Brian Ember
    Chief Executive Officer of AgPlenus Ltd
    Dr. Elran Hillel Haber M.B.A., Ph.D.
    Chief Executive Officer of Biomica Ltd
    Mr. Amit Noam Capt. res.
    Chief Executive Officer of Lavie Bio Ltd.
    Mr. Yaron Eldad
    Chief Financial Officer
    Rachel Pomerantz Gerber
    Head of Investor Relations
    Mr. Sassi Masliah
    Vice President of Corporate Development
    Ms. Liat Foigel Wejgman
    Vice President of Human Resources
    Mr. Eyal Ronen
    Executive Vice President of Business Development
    Mr. Yoash Zohar
    Chief Executive Officer of Casterra Ag Ltd.

    Important FAQs about investing in EVGN Stock from India :

    What is Evogene share price today?

    Evogene share price today stands at $1.47, Open: $1.49 ; Previous Close: $1.47 ; High: $1.55 ; Low: $1.45 ; 52 Week High: $10.40 ; 52 Week Low: $1.20.

    The stock opens at $1.49, after a previous close of $1.47. The stock reached a daily high of $1.55 and a low of $1.45, with a 52-week high of $10.40 and a 52-week low of $1.20.

    Can Indians buy Evogene shares?

    Yes, Indians can invest in the Evogene (EVGN) from India.

    With INDmoney, you can buy Evogene at 0 brokerage. The step-by-step process is as follows:

    • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
    • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
    • Once funds are transferred successfully, you can buy Evogene at zero transaction cost.

    How can I buy Evogene shares from India?

    It is very easy to buy Evogene from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

    Can Fractional shares of Evogene (EVGN) be purchased?

    Yes, you can buy fractional shares of Evogene with INDmoney app.

    What are the documents required to start investing in Evogene stocks?

    To start investing in Evogene, You will need the following documents:

    • Proof of Identification (PAN, Aadhaar etc)
    • Proof of address (Aadhaar, Voter ID etc)

    These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

    What are today’s High and Low prices of Evogene Stock (EVGN)?

    Today’s highest price of Evogene (EVGN) is $1.55.

    Today’s lowest price of Evogene (EVGN) is $1.45.

    What is today's market capitalisation of Evogene?

    Today's market capitalisation of Evogene EVGN is 10.2M

    What is the 52 Week High and Low Range of Evogene Stock (EVGN)?

    • 52 Week High

      $10.40

    • 52 Week Low

      $1.20

    What are the historical returns of Evogene (EVGN)?

    • 1 Month Returns

      -20.54%

    • 3 Months Returns

      -65.41%

    • 1 Year Returns

      -80.66%

    • 5 Years Returns

      -90.45%

    Who is the Chief Executive Officer (CEO) of Evogene ?

    Mr. Ofer Haviv CPA is the current Chief Executive Officer (CEO) of Evogene.